Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
Hangzhou Coco Healthcare Products
301009
CN Stock MarketDetailed Quotes
000985 Daqing Huake
- 21.59
- -0.59-2.66%
Trading Dec 16 10:41 CST
2.80BMarket Cap56.08P/E (TTM)
22.83High21.40Low35.34KlotVolume22.62Open22.18Pre Close77.90MTurnover2.73%Turnover Ratio490.68P/E (Static)129.64MShares23.8052wk High4.57P/B2.80BFloat Cap10.1852wk Low24.40Limit Up129.64MShs Float37.58Historical High19.96Limit Down6.45%Amplitude3.13Historical Low0.02Dividend TTM22.04Avg Price18.30KlotAsk0.08%Div YieldTTM100Lot Size14.76KlotBid
Daqing Huake Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 4.41%1.51B | -13.27%967.67M | -23.26%482.82M | -23.34%2B | -29.42%1.44B | -16.14%1.12B | 2.02%629.17M | 25.83%2.61B | 32.75%2.04B | 33.20%1.33B |
| Operating revenue | 4.41%1.51B | -13.27%967.67M | -23.26%482.82M | -23.34%2B | -29.42%1.44B | -16.14%1.12B | 2.02%629.17M | 25.83%2.61B | 32.75%2.04B | 33.20%1.33B |
| Other operating revenue | ---- | 167,216.91%525.63K | ---- | 273.37%908.8K | ---- | --314.15 | ---- | --243.41K | ---- | --0 |
| Total operating cost | 0.12%1.45B | -14.41%950.58M | -23.49%476.49M | -23.25%1.99B | -28.10%1.45B | -15.92%1.11B | 3.53%622.78M | 25.83%2.59B | 32.44%2.02B | 33.18%1.32B |
| Operating cost | 0.66%1.39B | -15.39%906.83M | -24.81%453.84M | -24.43%1.89B | -28.67%1.38B | -15.24%1.07B | 5.26%603.61M | 28.40%2.51B | 34.57%1.93B | 35.34%1.26B |
| Operating tax surcharges | -3.26%7.68M | 62.32%5.36M | 193.96%3.09M | 173.90%18.9M | 43.29%7.94M | -5.64%3.3M | -43.26%1.05M | 6.49%6.9M | 6.61%5.54M | 9.05%3.5M |
| Operating expense | -22.79%2.06M | -29.21%1.37M | -33.98%696.2K | -27.11%3.38M | -33.71%2.67M | -36.73%1.93M | -30.85%1.05M | -30.37%4.63M | -20.03%4.02M | -0.05%3.06M |
| Administration expense | 5.92%58.09M | 31.35%40.32M | 27.72%20.99M | 10.45%71.3M | -16.55%54.85M | -31.58%30.7M | -26.76%16.43M | -30.57%64.55M | -10.78%65.72M | -8.18%44.87M |
| Financial expense | -5.58%-4.8M | 7.69%-3.41M | 23.78%-2.13M | -25.28%-8.2M | -32.27%-4.54M | -60.80%-3.69M | -97.95%-2.79M | -11.94%-6.55M | 11.32%-3.44M | -15.93%-2.3M |
| -Interest expense (Financial expense) | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Interest Income (Financial expense) | -5.46%-4.82M | 7.85%-3.42M | 23.81%-2.13M | -31.52%-7.97M | -31.86%-4.57M | -60.12%-3.71M | -97.20%-2.8M | -1.31%-6.06M | 11.39%-3.46M | -15.67%-2.32M |
| Research and development | -95.50%451.78K | -98.39%106.53K | --0 | -37.55%10.05M | -11.49%10.04M | -8.86%6.62M | -6.81%3.43M | 112.11%16.09M | 89.57%11.34M | 68.01%7.26M |
| Credit Impairment Loss | 308.85%505.24 | 308.85%505.24 | --505.24 | 215.65%392.37 | -409.11%-241.91 | -409.11%-241.91 | --0 | -115.98%-339.28 | -96.19%78.26 | -96.19%78.26 |
| Asset Impairment Loss | -64.86%-11.4M | 11.65%-5.83M | 99.74%-12.05K | -84.25%-11.44M | -229.08%-6.92M | -409.36%-6.6M | -499.48%-4.57M | -54.72%-6.21M | 24.25%-2.1M | 53.29%-1.3M |
| Other net revenue | -172.11%-11.52M | -33.04%-6.57M | 57.70%-1.59M | -195.83%-7.12M | -463.66%-4.23M | -575.36%-4.94M | -6,021.19%-3.77M | -361.43%-2.41M | -0.75%1.16M | 178.63%1.04M |
| Fair value change income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Invest income | 0.00%63.79K | 0.00%63.79K | 0.00%63.79K | -40.00%63.79K | -40.00%63.79K | -40.00%63.79K | -40.00%63.79K | 150.00%106.31K | 150.00%106.31K | 150.00%106.31K |
| Net open hedge income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Including: Investment income associates | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Exchange income | 36.05%272.41K | 62.63%301.11K | 296.26%114.01K | ---- | -55.95%200.24K | -22.82%185.16K | 1,009.35%28.77K | ---- | 884.25%454.55K | 726.57%239.92K |
| Asset deal income | ---2.41M | ---2.41M | ---2.42M | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other revenue | -19.07%1.96M | -7.30%1.31M | -7.23%659.96K | 15.13%4.26M | -10.63%2.42M | -29.03%1.41M | -1.62%711.39K | -24.40%3.7M | -31.70%2.71M | 37.50%1.99M |
| Operating profit | 412.37%41.33M | 8,878.85%10.52M | 80.52%4.73M | -74.74%3.74M | -150.65%-13.23M | -98.89%117.15K | -82.78%2.62M | 1.13%14.8M | 59.44%26.12M | 85.27%10.59M |
| Add:Non operating Income | 354.73%337.66K | 526.42%334.8K | 514.42%324.37K | 18.81%430.67K | 144.82%74.26K | 117.88%53.45K | 115.56%52.79K | 38.01%362.49K | -88.42%30.33K | -88.46%24.53K |
| Less:Non operating expense | --157.25K | --157.25K | --157.25K | --50.47K | ---- | ---- | --0 | ---- | ---- | ---- |
| Total profit | 415.50%41.51M | 6,169.92%10.7M | 83.21%4.9M | -72.84%4.12M | -150.31%-13.16M | -98.39%170.6K | -82.47%2.67M | 11.33%15.16M | 70.17%26.15M | 100.21%10.62M |
| Less:Income tax cost | --10.38M | 10,349.87%2.67M | 205.35%1.22M | -527.42%-1.56M | ---- | -98.39%25.59K | -82.47%401.15K | -132.05%-248.48K | 69.17%3.92M | 95.20%1.59M |
| Net profit | 336.63%31.13M | 5,432.29%8.02M | 61.66%3.67M | -63.16%5.68M | -159.19%-13.16M | -98.39%145.01K | -82.47%2.27M | 19.98%15.41M | 70.35%22.23M | 101.12%9.03M |
| Net profit from continuing operation | 336.63%31.13M | 5,432.29%8.02M | 61.66%3.67M | -63.16%5.68M | -159.19%-13.16M | -98.39%145.01K | -82.47%2.27M | 19.98%15.41M | 70.35%22.23M | 101.12%9.03M |
| Net profit of parent company owners | 336.63%31.13M | 5,432.29%8.02M | 61.66%3.67M | -63.16%5.68M | -159.19%-13.16M | -98.39%145.01K | -82.47%2.27M | 19.98%15.41M | 70.35%22.23M | 101.12%9.03M |
| Earning per share | ||||||||||
| Basic earning per share | 335.29%0.24 | 6,100.00%0.062 | 55.56%0.028 | -63.19%0.0438 | -159.65%-0.102 | -98.57%0.001 | -82.00%0.018 | 20.20%0.119 | 69.31%0.171 | 100.00%0.07 |
| Diluted earning per share | 335.29%0.24 | 6,100.00%0.062 | 55.56%0.028 | -63.19%0.0438 | -159.65%-0.102 | -98.57%0.001 | -82.00%0.018 | 20.20%0.119 | 69.31%0.171 | 100.00%0.07 |
| Other composite income | ||||||||||
| Total composite income | 336.63%31.13M | 5,432.29%8.02M | 61.66%3.67M | -63.16%5.68M | -159.19%-13.16M | -98.39%145.01K | -82.47%2.27M | 19.98%15.41M | 70.35%22.23M | 101.12%9.03M |
| Total composite income of parent company owners | 336.63%31.13M | 5,432.29%8.02M | 61.66%3.67M | -63.16%5.68M | -159.19%-13.16M | -98.39%145.01K | -82.47%2.27M | 19.98%15.41M | 70.35%22.23M | 101.12%9.03M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
